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The aim of this study was to determine the role of focal adhesion kinase (FAK) in the phenotypic shift between fibroblasts and myofibroblasts, two cell types important in wound healing. Signals from transforming growth factor beta (TGF␤) and fibronectin induce fibroblasts to differentiate into smooth muscle ␣-actin (SM␣A)-expressing myofibroblasts, whereas fibroblast growth factor and heparin (FGF/h) induce myofibroblasts to loose SM␣〈 expression and dedifferentiate into fibroblasts. Because we found that FAK was not necessary for TGF␤-mediated myofibroblast differentiation, but FAK was necessary for FGF/h-mediated inhibition of myofibroblast differentiation, we embarked on the elucidation of the role of FAK role in FGF signaling.
PRINCIPAL FINDINGS

The absence of FAK leads to unregulated myofibroblast differentiation
Earlier reports implicated TGF␤-induced fibronectin signaling and FAK in myofibroblast differentiation. This led to the prediction that in the absence of FAK, cells would remain fibroblasts even after TGF␤ treatment. To evaluate this, we used mouse embryonic fibroblasts (MEFs) lacking or expressing FAK (FAK Ϫ/Ϫ and FAK ϩ/ϩ) and counted the number of cells in which SM␣A was expressed and incorporated into stress fibers, a phenotype of differentiated myofibroblasts ( Fig. 1) . We studied the cells in serum-free medium in the absence of added growth factors, or with TGF␤ to promote the myofibroblast phenotype (SM␣A expression) or with FGF/h to promote the fibroblast phenotype (lack of SM␣A expression). In contrast to the prediction, FAK Ϫ/Ϫ MEFs were myofibroblasts under all three growth conditions. Most notably after treatment with FGF/h, FAK Ϫ/Ϫ MEFs remained as myofibroblasts, (Fig. 1C, D , FAK Ϫ/Ϫ: 95% myofibroblasts), whereas FAK ϩ/ϩ MEFs (Fig. 1A, B) , and DA2 (FAK re-expressing) MEFs, (Fig. 1E, F) , were predominately fibroblasts (FAK ϩ/ϩ: 2%, and DA2: 3% myofibroblasts). Thus, FAK was not only dispensable for myofibroblast formation, but the absence of FAK promoted the myofibroblast phenotype.
We found that both FAK ϩ/ϩ MEFs and FAK Ϫ/Ϫ MEFs secreted comparable amounts of active TGF␤. We posit that this secreted TGF␤ stimulates SM␣A expression and thus myofibroblast differentiation. We determined that both cell types have the ability to respond to exogenous TGF␤ with SM␣A synthesis. However, we found that FGF/h treatment decreases SM␣A expression only in cells expressing FAK. Thus FAK was necessary for FGF-mediated negative regulation of SM␣A expression.
FAK shRNA decreases FAK and increases SM␣A protein expression
Using an alternative approach to decrease FAK protein expression in the MEFs, we nucleofected FAKϩ/ϩ MEFs with FAK short hairpin RNA (shRNA). As determined by immunoblotting and immunofluorescence expression of FAK shRNA in FAK ϩ/ϩ MEFs greatly decreased FAK protein expression. Concomitantly with the decrease in FAK concentration, there was a strongly decreased response to FGF, which was reflected in its inability to inhibit myofibroblast differentiation. After FGF/h treatment, only 18% of FAK ϩ/ϩ MEFs (nucleofected with empty vector) were myofibroblasts, whereas 64% of MEFs, in which FAK was knocked down, remained as myofibroblasts.
mediates its effect by binding to its receptor (FGFR) and activation of a signaling cascade. To evaluate whether FAK was required for FGFR expression, we measured the cell surface expression of FGFRs by incubation of cells with [
125 I] FGF-2. We found that FAK Ϫ/Ϫ MEFs, bound 50% less [
125 I] FGF-2, as compared to FAK ϩ/ϩ and DA2 MEFs (Fig. 2 A, B) . Furthermore, FGFR phosphorylation in FGF/htreated FAK Ϫ/Ϫ MEFs was significantly decreased as compared to FAK ϩ/ϩ MEFs (Fig. 2C) . The difference in phosphorylation is greater than the 50% difference in FGFR expression. This may be because FGFRs signal synergistically, or FAK may directly contribute to FGFR phosphorylation.
FAK is necessary for FGF signaling via FGF receptor substrate 2 (FRS2) and extracellular signal-regulated kinase (ERK)
FRS2 is the immediate downstream substrate of FGFRs, which links FGF signaling to ERK activation. We showed that in FAK Ϫ/Ϫ MEFs treatment with FGF/h induced little or no phosphorylation of FRS2 (Fig. 2D) , nor of ERK. In contrast, in FAK ϩ/ϩ MEFs, treatment with FGF/h induced strong phosphorylation of FRS2 (Fig. 2D) , and ERK. This is the first report that establishes a role for FAK in regulating signaling through the FGF/FRS2/ERK pathway.
In summary, the absence of FAK coincided with reduced FGFR surface expression and activity, decreased FGF signaling via the FGFR/FRS2/ERK pathway, and increased expression of SM␣A. Thus, FAK plays a crucial role in FGF signaling, and FAK is necessary for FGF-mediated maintenance of the fibroblast phenotype and myofibroblast de-differentiation, but not for TGF␤-induced differentiation to the myofibroblast phenotype.
CONCLUSIONS AND SIGNIFICANCE
This is the first report that establishes a role for FAK in promoting FGF signaling and in FGF-mediated downregulation of SM␣A, a marker of myofibroblasts. In cells in which FAK protein was greatly reduced by shRNA or entirely absent (FAK Ϫ/Ϫ MEFs), treatment with FGF failed to decrease SM␣A expression. Furthermore, in the absence of FAK, FGFRs surface expression and signals downstream of FGF were decreased.
We propose a working model that implicates FAK in regulation of myofibroblast differentiation by integrating two different growth factor pathways (Fig. 3) . Our model starts with previous data; as TGF␤ induces myofibroblast differentiation, it also increases expression of integrins and fibronectin (Fig. 3, step 1) . Integrin binding to fibronectin activates FAK in TGF␤-mediated myofibroblast differentiation (Fig. 3, step 2) . FAK activation leads to increased cell-surface expression of FGFRs by increased retention of FGFR in the cell membrane and/or by increased FGFR gene expression (Fig. 3, step 3 ). Increased cell-surface expression of FGFRs transmits FGF signals and increases activation of the FGF pathway via FRS2/ERK (Fig. 3, step 4) , which negatively regulates the levels of SM␣A (Fig. 3, step 5) . Our model includes a role for FAK in FGF inhibition of SM␣A induction due to the fact that the absence of FAK makes cells refractory to FGF/h-mediated inhibition of SM␣A expression. We hypothesize that in vivo, FAK activation by TGF␤ may contribute to a negative feedback mechanism that prevents excessive myofibroblast differentiation, which is linked to fibrosis. Failure to down-regulate extracellular matrix (ECM) deposition and/or SM␣A stress fiber formation on wound closure has been linked to fibrosis. Our results suggest that FAK activation could inhibit myofibroblast differentiation, reduce their proportion in a tissue, and ameliorate fibrosis. These insights add to our knowledge of molecular mechanisms of fibrosis and hopefully contribute to improved approaches to wound healing. During wound repair, fibroblasts at the wound margin differentiate into myofibroblasts, exemplified by their SM␣A containing stress fibers (1-6). The force generated by integrin-mediated interaction between SM␣A stress fiber terminals and the extracellular matrix (ECM) contributes to wound closure (4, (7) (8) (9) (10) (11) (12) . In a properly healed wound, few myofibroblasts remain and the persistence of myofibroblasts correlates with fibrosis (1, 5, (13) (14) (15) (16) (17) . Thus, understanding the pathways that influence myofibroblast differentiation in a wound will contribute to promoting healthy repair. Previous studies show that in fibroblasts TGF␤ induces expression and incorporation into stress fibers of SM␣A, which is synonymous with myofibroblast differentiation (1, 3, 18 -23) . TGF␤ also induces fibronectin synthesis, secretion, and incorporation into the ECM, as well as expression of fibronectin integrins (17, 18, 24 -31) . Signals from both TGF␤ and fibronectin are required to promote myofibroblast differentiation in many tissues (3, 21, 26, 30, (32) (33) (34) (35) (36) (37) . Integrin-mediated fibronectin signals are transmitted by FAK, a 120-kDa nonreceptor protein tyrosine kinase. Focal adhesion kinase F-actin (FAK) is localized to focal adhesions where it is activated by phosphorylation after integrinmediated cell attachment (38 -42) . Thus, it was hypothesized that FAK would transduce the integrin-mediated fibronectin signals that promoted SM␣A expression and stress fiber organization, and thus myofibroblast differentiation. Given that 1) TGF␤ stimulates expression of SM␣A, fibronectin and fibronectin integrins and that 2) FAK transmits signals from fibronectin integrins, we reasoned that myofibroblast differentiation induced by TGF␤ and fibronectin would be FAK dependent.
We took advantage of the availability of MEFs lacking FAK to explore the role of FAK in regulating the differentiation of fibroblasts to myofibroblasts. On the basis of the previous studies described above implicating fibronectin signaling and FAK in myofibroblast differentiation, we predicted that in the absence of FAK, MEFs would remain fibroblasts even after TGF␤ treatment. In contrast to this prediction, in the absence of FAK, MEFs strongly expressed SM␣A in stress fibers even without treatment with exogenous TGF␤. However, FAK was necessary for FGF/h signaling and downregulation of SM␣A expression. These results were confirmed in FAKϩ/ϩ MEFs where FAK was greatly decreased by expression of shRNA specific for FAK. In the absence of FAK, FGFR surface expression and signals downstream of FGF were decreased. This is the first report to establish a role for FAK in promoting FGF signaling. Our data demonstrate that FAK plays a role in down-regulating SM␣A. FAK's regulation of myofibroblast differentiation may significantly contribute to preventing fibrosis.
MATERIALS AND METHODS
Cell culture
MEFs obtained and grown as described were FAK ϩ/ϩ and FAK Ϫ/Ϫ MEFs (43), FAK Ϫ/Ϫ (hygro), DA2 (FAK reexpressing) (44) , and Src/Fyn/Yes Ϫ/Ϫ (45). FAK Ϫ/Ϫ (hygro) and DA2 MEFs, were grown on 0.1% gelatin-coated coverslips or cell culture dishes. All MEFs were passaged by addition of 0.5 ϫ trypsin, EDTA (Invitrogen, Carlsbad, CA) and were split 1:3 to 1:10. For growth factor treatment MEFs were grown in supplemented serum-fee medium (SSFM): DMEM/F-12 (Invitrogen) with antibiotic-antimycotic, 50 g/ml gentamicin solution, RPMI 1640 Vitamin Mix, ITS Liquid media supplement (5 g/ml each of insulin, transferrin, and 0.05 g/ml sodium selenite), 1 g/ml glutathione, (Sigma, St. Louis, Mo); 1 mM sodium pyruvate, 0.1 mM MEM nonessential amino acids. To promote the fibroblast phenotype in cultures of Src/Fyn/Yes Ϫ/Ϫ, FAK ϩ/ϩ and DA2 MEFs, we added 1-20 ng/ml FGF-2 (Invitrogen, Carlsbad, CA) and 5 g/ml heparin (Sigma) to SSFM. To induce the myofibroblast phenotype, we added 1 ng/ml TGF␤ (BD Biosciences Transduction, San Diego, CA) to SSFM. For serum starvation conditions, MEFs were incubated in serum free media with 0.2% BSA (Serologicals Corp., Norcross, GA) for 3 h (46), and treated with growth factors for times indicated.
FAK shRNA and electroporation
The FAK shRNA expression construct, pSHAG/mFAK24, was designed and created as described (47) . The construct contains FAK shRNA sequences (29-mer) oligonucleotides ligated into the vector pSHAG, and was shown to decrease FAK protein expression in FAK ϩ/ϩ MEFs (47). To introduce FAK shRNA into FAK ϩ/ϩ MEFs, electroporation of pSHAG/mFAK24 was performed on the Nucleofector device (Amaxa Biosystems, Köln, Germany). We used the MEF2 Nucleofector Kit (Amaxa Biosystems) according to the manufacturer's protocol. 6.6 g of pSHAG-mFAK24 or empty vector (pSHAG), and 4.4 g enhanced GFP (EGFP)-C1 (BD Clontech, Palo Alto, CA) was electroporated per 2 ϫ 10 6 FAK ϩ/ϩ MEFs. By including EGFP-C1 in the electroporation, we determined by fluorescence microscopy that 80% of MEFs contained the plasmids.
Antibodies
All antibodies were purchased from commercial sources; Mouse anti-ERK (MK12), (BD Transduction, San Diego, CA); mouse antiphosphorylated ERK 1/2 (E4), rabbit-anti FRS2 (H-91) and rabbit-anti FGFR1 (flg; C-15) (Santa Cruz Biotechnology, Santa Cruz, CA); mouse and rabbit anti-FAK (neither cross-reacts with Pyk2), and mouse antiphosphotyrosine (4G10) (Upstate Biotechnology, Lake Placid, NY); mouse anti-tubulin (B512), mouse anti-SM␣A (1A4), and mouse anti-SM␣A cy3 or FITC conjugate (Sigma); goat antimouse and goat anti-rabbit conjugated to either Alexa 488, Alexa 568, or Alexa 647 (Molecular Probes, Eugene, OR); rabbit gamma globulin, mouse gamma globulin, goat antimouse and goat anti-rabbit conjugated to HRP (Jackson ImmunoResearch Laboratories, West Grove, PA).
Immunofluorescence
MEFs were grown on 12-mm glass coverslips, and fixed by 3% paraformaldehyde (Fisher Scientific, www.Fishersci.com) in PBS, for 15 min at 25°C. Immunodetection was performed as described (29) . All cells were viewed with a Zeiss Axioskop, or Zeiss Axiovert 200 microscope equipped with CCD cameras. In Fig. 1A and B, optical sections were generated by inserting an ApoTome slider (Carl Zeiss, Thornwood, NY) into the illumination path on a Zeiss Axiovert 200 equipped with a ϫ63 objective lens. The ApoTome slider projected a series of three shifted images of a grid of lines onto the focal plane (i.e., grid projection or "structured illumination"). The images were subsequently combined, and the out-of-focus haze removed using AxioVision software (Carl Zeiss) and images collected on an Axiocam MRm CCD camera. All images were processed by Adobe PhotoShop software. All experiments were performed at least 3 times with similar results obtained, and representative images are shown.
Immunoprecipitation, SDS-PAGE and immunoblotting
MEFs were lysed in modified radio-immunoprecipitation assay (RIPA) buffer: (150 mM NaCl, 2 mM EDTA, 1% DOC, 0.1% SDS, 1% Triton X-100, 10% glycerol, 50 mM HEPES (pH 7.5), 100 mM NaF, 3 mM sodium vanadate, 10 mM sodium pyrophosphate, Complete TM EDTA-free protease inhibitors (Roche Diagnostics, Munich, Germany), and 1 mM PMSF), or 1% SDS lysis buffer (1% SDS, 10 mM Tris pH, 7.6, Complete TM EDTA-free protease inhibitors, and 1:2,000 dilution of Benzonase (Sigma) added after lysis. For immunoprecipitation, lysates were precleared with Protein A-sepharose beads (Sigma) for 20 min, 4°C. Precleared lysates were mixed with primary antibodies and incubated overnight at 4°C. To each lysate, 40 l protein A-sepharose beads were added and incubated for 60 min at 4°C. The beads were then collected by centrifugation, 3,000 rpm, and washed 4 times in lysis buffer followed by 1ϫ PBS wash. The immune-bead-associated complexes were eluted with 1ϫ SDS sample buffer in PBS with boiling for 10 min. Lysates or immunoprecipitated bead supernatants were separated by 7.5% or 10% (Fig. 3 only) SDS-PAGE, transferred to Protran™ nitrocellulose (Schleicher and Schuell, Keene, NH) or PVDF (Millipore, Bedford, MA) membranes and immunodetection performed as described (29) . Chemiluminescence was visualized on a Kodak Image Station 440CF (Kodak) or on Kodak BioMax MS film (Fisher Scientific). Densitometry was performed using Kodak 1D software. Where indicated, blots were reprobed after stripping using Restore Western blot Stripping buffer (Pierce, Rockford, IL).
TGF␤ assay of MEF conditioned media
MEFs were plated at 3 ϫ 10 4 cells per well in 24-well dishes in DMEM/F-12 containing 10% FBS. After cells attached, the medium was replaced by SSFM with or without 20 ng/ml FGF-2 and 5 g/ml heparin. Conditioned media was collected after 1, 2, and 3 days of growth in SSFM. To assay the amount of TGF␤ in media, we used a well-documented, standard assay: Mink lung epithelial cells (MLECs) stably transfected with the promoter fragment of the human PAI-1 
Statistical analysis
Statistical differences between experimental groups were determined by ANOVA and values of P Ͻ 0.05 were considered significant (54) 
RESULTS
The absence of FAK leads to unregulated myofibroblast differentiation
On the basis of the studies implicating FAK in fibronectin signaling and in myofibroblast differentiation, we predicted that in the absence of FAK, (FAK Ϫ/Ϫ) MEFs would remain fibroblasts even after TGF␤ treatment. However, we found that FAK Ϫ/Ϫ MEFs had SM␣A stress fibers without addition of exogenous TGF␤. Furthermore, whereas FGF/h-treated FAK ϩ/ϩ (Fig. 1A, B) , and DA2 (FAK re-expressing) MEFs (Fig.  1E, F) , expressed little SM␣A protein and thus were predominantly fibroblasts, (FAK ϩ/ϩ: 2%, and DA2: 3% myofibroblasts), FAK Ϫ/Ϫ MEFs had SM␣A stress fibers (Fig. 1C , D, FAK Ϫ/Ϫ: 95% myofibroblasts). Increasing FGF-2 concentration to 50 ng/ml did not cause FAK Ϫ/Ϫ MEFs to loose their SM␣A stress fibers and become fibroblasts (data not shown). Thus, FAK was not only dispensable for myofibroblast differentiation, but the absence of FAK promoted the myofibroblast phenotype. Next, we tested whether FAK was necessary for TGF␤-induced-myofibroblasts to "de-differentiate" to fibroblasts in response to FGF/h. We found that FGF/h treatment reversed the TGF␤-induced myofibroblast phenotype in FAK ϩ/ϩ MEFs but not in FAK Ϫ/Ϫ MEFs (compare Fig. 2 with Fig. 1D ). On the basis of the inability of FGF to induce the fibroblast phenotype in FAK Ϫ/Ϫ MEFs, we concluded that FAK was necessary for FGF-mediated negative regulation of SM␣A expression. 
FAK shRNA decreases FAK and increases SM␣A protein expression
To confirm that the absence of FAK promoted the myofibroblast phenotype, we used FAK shRNA to decrease FAK protein expression. As determined by immunoblotting (Fig. 3A) and immunofluorescence ( Fig.  3B) , FAK shRNA decreased FAK protein expression in FAK ϩ/ϩ MEFs as compared to MEFs containing the empty vector. Furthermore, knockdown of FAK inhibited FGF-mediated decrease in SM␣A, (Fig. 3A, B) . After FGF/h treatment, 64% of FAK ϩ/ϩ MEFs expressing the FAK-shRNA were myofibroblasts as compared to 18% of FAK ϩ/ϩ MEFs nucleofected with empty vector (Fig. 3B) . Thus knockdown of FAK protein, not only the knockout of FAK, decreased FGFmediated inhibition of myofibroblast differentiation.
FAK ؊/؊ MEFs and FAK ؉/؉ MEFs secrete comparable amounts of active TGF␤
Increased expression of SM␣A in FAK Ϫ/Ϫ MEFs could reflect more secretion of active TGF␤ by FAK Ϫ/Ϫ MEFs as compared to FAK ϩ/ϩ MEFs. To test this hypothesis, we measured active TGF␤ in conditioned media of MEFs using the standard MLEC luciferase assay (48) , (see Materials and Methods). We found that FAK ϩ/ϩ MEFs and FAK Ϫ/Ϫ MEFs secreted comparable amounts of active TGF␤ (Fig. 4) . Thus, it was the FAK Ϫ/Ϫ MEFs inability to respond to the FGF/h signal, and not a differential increase in TGF␤, which caused FAK Ϫ/Ϫ MEFs to have increased SM␣A expression (Figs. 1-3 ). On the basis of these results, we explored FAK's role in the FGF signaling pathway.
Src/Fyn/Yes ؊/؊ MEFs respond to growth factormediated regulation of phenotypes
Because Src family tyrosine kinases are involved in both FGF and FAK signaling, we posed the question of whether Src family tyrosine kinases mediated FAK's negative regulation of the SM␣A expression. We used MEFs null for the ubiquitously expressed Src family kinases Src, Fyn, and Yes. Src/Fyn/Yes Ϫ/Ϫ MEFs responded to FGF/h by decreasing SM␣A expression (Fig. 5A, B) and to TGF␤ by increasing SM␣A expression (Fig. 5C, D) . Therefore, we concluded that these Src family kinases do not play a role in this phenotype modulation.
FAK affects FGF receptor signaling
Having determined that FAK Ϫ/Ϫ MEFs were defective in FGF/h-dependent inhibition of SM␣A expression, we sought to identify the mechanism of FAK's regulation of FGF signaling. (Fig. 6A, B) . Furthermore, FGFR phosphorylation in FGF/h-treated FAK Ϫ/Ϫ MEFs was significantly decreased compared to FAK ϩ/ϩ MEFs (Fig. 6C) .
FAK is necessary for FGF signaling via FRS2 and ERK
FRS2 is immediately downstream from FGFRs and links FGF signaling to ERK activation. We asked whether FGF signaling through FRS2 and ERK was decreased in FAK Ϫ/Ϫ MEFs. Treatment of FAK ϩ/ϩ MEFs with FGF/h induced the phosphorylation of FRS2 (Fig. 6D) and ERK (Fig. 7) . In contrast, treatment of FAK Ϫ/Ϫ MEFs with FGF/h induced little or no phosphorylation of FRS2 (Fig. 6D) , nor ERK (Fig. 7) . Thus, FAK was necessary for efficient FGF signaling to ERK. This is the first report to establish a role for FAK in regulating signaling through the FGF/FRS2/ERK pathway. In summary, in the absence of FAK, there was reduced FGFR surface expression and activity, and decreased FGF signaling via the FGFR/FRS2/ERK pathway.
DISCUSSION
The data presented here can be organized into a working model of TGF␤/FGF signaling in myofibroblast differentiation that alters the current paradigm. The established roles of TGF␤ in increasing fibronectin in myofibroblast differentiation, and FAK in modulating signals from fibronectin had suggested that FAK would contribute to TGF␤-mediated myofibroblast differentiation. In contrast, we found that the absence of FAK curtailed the optimal functioning of FGF signaling in myofibroblast de-differentiation or maintaining the fibroblast phenotype. Where FAK was greatly decreased (by shRNA) or absent (FAK Ϫ/Ϫ MEFs), SM␣A was expressed in stress fibers even after addition of FGF/h to cells. Furthermore, in the absence of FAK, FGFR surface expression was greatly reduced as was phosphorylation of FRS2 and ERK, which are downstream from FGFRs. Thus we postulate that FAK is necessary for FGF signaling via FRS2/ERK, and that these signals Figure 3 . FAK shRNA inhibited FAK expression and increased SM␣A expression. FAK ϩ/ϩ MEFs were electroporated with pSHAG-shRNA24 containing FAK-shRNA or with empty vector. By including EGFP-C1 in the electroporation, we determined by fluorescence microscopy that 80% of MEFs contained the plasmids. After electroporation, MEFs were incubated with or without 5 ng/ml FGF-2 and 5 g/ml heparin in SSFM for 3 days. A) In immunoblots of FAK-shRNA expressing FAK ϩ/ϩ MEFs, 1, FAK expression was decreased, and 3, SM␣A expression was increased. Cell lysates were analyzed for 1, FAK, and 3, SM␣A. After detection, blots were stripped, and reprobed for, 2, tubulin, as a loading control. 4, Bar graph for normalization of SM␣A band intensity. The ratio of SM␣A/tubulin band intensities for untreated empty vector was made equal to 1. Values are means from two independent experiments Ϯ range. *P Ͻ 0.05, empty vector without FGF/h compared to empty vector with FGF/h. ** P Ͻ 0.05, empty vector with FGF/h compared to shRNA with FGF/h. B) MEFs were incubated with 5 ng/ml FGF-2 and 5 g/ml heparin in SSFM for 3 days. FAK was detected in 1, MEFs nucleofected with empty vector, which did not express 2, SM␣A. In contrast, FAK was not detected in 3, FAK-shRNA expressing MEFs, which 4, had increased SM␣A expression in stress fibers, as compared to 2, empty vector controls. MEFs were fixed and immunodetected for both FAK and SM␣A with 1, 3, monoclonal anti-FAK, followed by secondary goat antimouse conjugated to Alexa 647 and 2,4, SM␣A-cy3. Scale bar ϭ 10 m. Percent myofibroblasts: empty vector: 18% Ϯ 11%; FAK-shRNA: 64% Ϯ 2%. Values are means from two independent experiments Ϯ range. P Ͻ 0.05, FAK-shRNA compared to empty vector. are involved in the negative regulation of SM␣A (Fig.  8) . This is the first report to establish a role for FAK in promoting FGF signaling and in FGF-mediated downregulation of SM␣A, and thus in opposing myofibroblast differentiation.
A major defect of FAK Ϫ/Ϫ MEFs is decreased migration because of decreased focal adhesion turnover (43, 44, 55, 56) . These data are consistent with our finding that FAK Ϫ/Ϫ MEFs are myofibroblasts because myofibroblasts are less migratory than fibroblasts (57) . After the initial formation of focal adhesions, it is likely that the high expression of SM␣A in FAK Ϫ/Ϫ MEFs stabilizes focal adhesions, increases mechanical tension, and contributes to decreased motility. This is consistent with the finding that inhibition of either SM␣A-mediated contractile activity (18, 58) or SM␣A expression (18, 57) increases focal adhesion and migration (18, 57, 58) . Matrix molecules like fibronectin may play a role in myofibroblast differentiation in a FAKindependent manner. This may be via p130
Cas and/or phosphatidylinositol 3-kinase (PI3K), which can be activated downstream from ␤ 1 integrins in FAK-independent pathways (59 -61) . Extracellular signals are likely to be transduced by ␤ 1 integrins since TGF␤ treatment of ␤ 1 Ϫ/Ϫ MEFs did not induce SM␣A expression (R. S. Greenberg, Thesis 2006).
FAK Ϫ/Ϫ MEFs bound 50% less FGF-2 on their cell surface than FAK-expressing FAK ϩ/ϩ, or DA2 MEFs (Fig. 6A, B) . The reduced expression of FGFRs on FAK Ϫ/Ϫ MEFs suggests that FAK contributes to reduced endocytosis and to enhanced retention of FGFRs in the cell membrane or to increased transcription of FGFRs genes. In fact, there is recent evidence for a positive role for FAK in regulating ␤ 1 integrins' cell surface residence. In FAK Ϫ/Ϫ, MEFs ␤ 1 integrins were endocytosed at a higher rate than in FAK ϩ/ϩ MEFs (62).
The additional role for FAK to provide signals that increase expression of FGFRs mRNA or protein is suggested by other data: E2F-mediated transcriptional activation of the FGFR1 and FGFR2 genes is induced by Cyclin D (63) (64) (65) , whose expression is increased by FAK (66, 67) .
Although the reduced expression of FGFRs on FAK Ϫ/Ϫ MEFs leads to decreased FGFR phosphorylation, the difference in FGFR phosphorylation between FAK Ϫ/Ϫ and FAK ϩ/ϩ MEFs is greater than the 50% difference in FGFR expression (Fig. 6C ). This may be because FGFRs signal synergistically, or FAK may directly contribute to FGFR phosphorylation.
Incorporating our data in a proposed model (Fig. 8 ), places FAK upstream of FGFR in a pathway that regulates SM␣A. The myofibroblast phenotype seems to be a default phenotype; input from FAK is required to maintain the fibroblast phenotype. In the absence of FAK, there is no FGF signaling via the FRS2/ERK pathway. This allows for unopposed TGF␤ signaling, and thus expression of SM␣A. When FAK is present, FGF signaling is intact and can overcome TGF␤-mediated myofibroblast differentiation. Another protein that is increased in TGF␤-mediated myofibroblast differentiation is smooth muscle protein 22-alpha (SM-22␣), (A.M. Bernstein and J. J. Tomasek unpublished observations). In cells treated simultaneously with FGF-2/h and TGF␤, there was decreased expression of SM-22␣. However, when an ERK inhibitor was added with these growth factors, the amount of SM-22␣ protein was not decreased (68) . This is consistent with our finding that ERK phosphorylation was absent in the FAK Ϫ/Ϫ myofibroblasts. These combined data suggest that ERK is involved in FGF/h-mediated inhibition of myofibroblast differentiation.
Our data indicate a role for FAK in positively con- tributing to FGF-dependent signaling, and down-regulating SM␣A expression. FAK activity early in wound healing would promote FGF-mediated fibroblast motility and would delay myofibroblast differentiation. In contrast, myofibroblast formation before FGF/FAKmediated proliferation and migration of fibroblasts could inhibit wound healing. These data can be integrated with previous studies that support a role for TGF␤-mediated activation of FAK in myofibroblast differentiation (31, 34): TGF␤ increases fibronectin and integrin expression (17, 18, 24 -31) , (Fig. 8, step 1) , which leads to FAK activation (Fig. 8, step 2) . So while TGF␤ induces SM␣A expression by one pathway, its activation of FAK leads to increased cell-surface expression of FGFRs by increased retention of FGFR in the cell membrane and/or by increased FGFR gene expression (Fig. 8, step 3) . Increased cell-surface expression of FGFRs transmits FGF signals and increases activation of the FGF pathway via FRS2/ERK (Fig. 8, step 4) , which negatively regulates the levels of SM␣A (Fig. 8, step 5 ). This is consistent with the data that show that when FAK was greatly decreased or absent, cells were refractory to FGF/h-mediated inhibition of SM␣A expression (Figs. 1-3 ). Our findings add FAK dependence to FGF's inhibition of SM␣A induction. We hypothesize that in vivo, FAK activation by TGF␤ may contribute to a negative feedback mechanism to prevent excessive myofibroblast differentiation, ameliorating fibrosis.
Although Src family tyrosine kinases are involved in both FGF and FAK signaling, our results with Src/Fyn/ Yes Ϫ/Ϫ MEFs indicate that the Src family tyrosine kinases are not required for FGF/FAK-mediated negative regulation of SM␣A expression (Fig. 5) . This is consistent with the finding that FGF-1 was able to induce phosphorylation of FRS2 in Src/Fyn/Yes Ϫ/Ϫ MEFs (69) . These data indicate that in Src/Fyn/Yes Ϫ/Ϫ MEFs there is sufficient FGF signaling to decrease SM␣A in response to FGF/h.
Failure to down-regulate ECM deposition and/or SM␣A stress fiber formation during wound closure has been linked to fibrosis (1, 5, 15, 17) . Inhibition of TGF␤-mediated SM␣A production was shown to reduce fibrosis in the skin (70, 71) and in the cornea (34, 72) . Furthermore, exogenous application of FGF-2 has been found to promote healing in the skin (73) , heart (74, 75) , and cornea (76 -79) . Our data suggest that reduction of FAK activation would negatively affect the ability of FGF to reduce SM␣A expression. Furthermore, activation of FAK and stimulation of FGF signaling could attenuate excess and irreversible SM␣A expression that is found in fibrosis. These insights add to our knowledge of molecular mechanisms of fibrosis and could contribute to interventions that promote successful wound healing. 
